Dr. Dov Tamarkin is a senior pharmaceutical executive, with over thirty years of experience. Between 2013 and 2017 he was Chief Executive Officer of Foamix Pharmaceuticals Ltd. (Nasdaq:FOMX). Prior to Foamix, Dr. Tamarkin held multiple executive positions at Teva Pharmaceuticals, Portman Pharmaceutical Industries, PowerPaper and TPI. He holds a Ph.D. degree in organic chemistry from The Hebrew University of Jerusalem, Israel; and he is the inventor of over a hundred patents in the pharmaceutical field.